Scholarlink

Background <p>Graphene-based nanomaterials are increasingly explored for cancer diagnosis and therapy, yet a comprehensive mapping of their scholarly landscape is lacking.</p> Methods <p>On 13 March 2025, a total of 4917 records (2016–2025) were retrieved from the Scopus database using a multistep search strategy. Bibliometric indicators were analyzed with Bibliometrix (R-package), VOSviewer, and CiteSpace to evaluate research growth, collaboration, intellectual structures, and thematic evolution.</p> Results <p>Publications grew at an annual rate of 2.97%, with China leading in both productivity and citations. Bradford’s Law identified 21 core journals, and leading contributors included LI Y and ZHANG Y. Collaboration networks showed dense interinstitutional and international links, particularly across Asia. Keyword and thematic analyses highlighted enduring focuses such as “graphene oxide,” “drug delivery,” and “biosensors,” while emerging trends included “plasmon resonance biosensor,” “brain tumor detection,” and advanced therapeutic applications. Co-citation and overlay mapping revealed conceptual shifts toward precision diagnostics and targeted therapies.</p> Conclusion <p>This study provides the first integrated bibliometric roadmap of graphene-based cancer research (2016–2025), outlining its growth trajectory, knowledge structures, and evolving themes. Findings inform researchers, funding agencies, and policymakers on current strengths, translational challenges, and priority directions for advancing graphene-based innovations in oncology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Global trends and knowledge structure of graphene based cancer research between 2016 and 2025

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月23日

查看全文
  • Manal Mohamed Elhassan Taha,
  • Siddig Ibrahim Abdelwahab,
  • Hazem Mathkour,
  • Edrous Alamer,
  • Saleh Mohammad Abdullah,
  • Saeed Alshahrani,
  • Nizar A. Khamjan,
  • Abdullah Farasani,
  • Ahmed S. Alamer,
  • Jobran M. Moshi,
  • Khaled A. Sahli,
  • Mohammed Jeraiby,
  • Marwa Qadri,
  • Abdulwahab Binjomah,
  • Khloud H. Alsaadi,
  • Hussam M. Shubaily,
  • Bandar Mushin Alamri

摘要

Background

Graphene-based nanomaterials are increasingly explored for cancer diagnosis and therapy, yet a comprehensive mapping of their scholarly landscape is lacking.

Methods

On 13 March 2025, a total of 4917 records (2016–2025) were retrieved from the Scopus database using a multistep search strategy. Bibliometric indicators were analyzed with Bibliometrix (R-package), VOSviewer, and CiteSpace to evaluate research growth, collaboration, intellectual structures, and thematic evolution.

Results

Publications grew at an annual rate of 2.97%, with China leading in both productivity and citations. Bradford’s Law identified 21 core journals, and leading contributors included LI Y and ZHANG Y. Collaboration networks showed dense interinstitutional and international links, particularly across Asia. Keyword and thematic analyses highlighted enduring focuses such as “graphene oxide,” “drug delivery,” and “biosensors,” while emerging trends included “plasmon resonance biosensor,” “brain tumor detection,” and advanced therapeutic applications. Co-citation and overlay mapping revealed conceptual shifts toward precision diagnostics and targeted therapies.

Conclusion

This study provides the first integrated bibliometric roadmap of graphene-based cancer research (2016–2025), outlining its growth trajectory, knowledge structures, and evolving themes. Findings inform researchers, funding agencies, and policymakers on current strengths, translational challenges, and priority directions for advancing graphene-based innovations in oncology.